⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002089237

Dennis Phillip Andrew

Reports to the SEC for 1 company · ROCKVILLE, MD

Transactions

6

Companies

1

Filings

2

CIK

0002089237

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-18	NBPNovaBridge BiosciencesS Sale	Chief Medical Officer	SSale	−8,209 sh	$0.71	−$5,828.39	173,427
2026-09-17	NBPNovaBridge BiosciencesM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+23.7K sh	—	—	181,636
2026-09-17	NBPNovaBridge Biosciences · Restricted Share UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10.3K sh	—	—	72,120
2026-06-18	NBPNovaBridge BiosciencesS Sale	Chief Medical Officer	SSale	−8,494 sh	$0.66	−$5,606.04	157,941
2026-06-17	NBPNovaBridge BiosciencesM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+23.7K sh	—	—	166,435
2026-06-17	NBPNovaBridge Biosciences · Restricted Share UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10.3K sh	—	—	82,422

Recent filings

2

Accepted (ET)
Sep 214
Dennis Phillip Andrew0002089237-26-000008
SEC(opens sec.gov)
Jun 224
Dennis Phillip Andrew0002089237-26-000006
SEC(opens sec.gov)

Companies

1

NovaBridge BiosciencesChief Medical OfficerNBP

Address

C/O NOVABRIDGE BIOSCIENCES 2440 RESEARCH BOULEVARD, SUITE 400

ROCKVILLE, MD, 20850